✨ 𝗪𝗵𝗮𝘁 𝗮𝗻 𝗶𝗻𝗰𝗿𝗲𝗱𝗶𝗯𝗹𝗲 𝘁𝘄𝗼 𝗱𝗮𝘆𝘀 𝗮𝘁 Adopt AI - Grand Palais ! A huge thank you to Gabriel Roteta Marañón, Sébastien Marguerès, Lyse De Oliveira and all the Artefact teams for delivering such a well-crafted event and bringing together an ecosystem that is shaping the future of AI. And what a setting : 𝘁𝗵𝗲 𝗚𝗿𝗮𝗻𝗱 𝗣𝗮𝗹𝗮𝗶𝘀, an exceptional venue that made the experience even more inspiring.✨ For Biolevate, these two days were packed with: 🔹 Valuable conversations with life science professionals, researchers, pharma leaders, and innovators, students... 🔹 Strong interest in GenAI with trust, governance, and real-world workflows 🔹 New perspectives and concrete needs that reinforce the importance of building AI that is auditable, scalable, and enterprise-ready Antoine de Torcy session drove strong engagement by highlighting why GenAI must move beyond simple chatbots, and how structured, end-to-end workflows unlock real value, traceability, and measurable impact across life sciences teams. 🙌 A sincere thank you to everyone who stopped by Biolevate's booth #AIforHealth #AdoptAISummit #GrandPalais #AIActionSummit #GenAI #TrustworthyAI #HealthcareInnovation
About us
At Biolevate, we believe that accelerating science means elevating humans. We help life science organizations turn their knowledge into scalable intelligence by connecting data, documents, and expertise across the enterprise. Our AI-native Knowledge Platform standardizes complex scientific workflows by connecting knowledge and reasoning. From unstructured content to structured insight, from isolated experts to organization-wide intelligence, your best practices become your standard. By freeing scientists, engineers, and experts from repetitive or manual work, Biolevate allows teams to focus on what truly matters: discovering, innovating, and advancing faster.
- Website
-
https://biolevate.com
External link for Biolevate
- Industry
- Software Development
- Company size
- 11-50 employees
- Type
- Privately Held
- Founded
- 2024
Employees at Biolevate
Updates
-
🚨 Day 2 at Adopt AI - Grand Palais After an exciting 1st day filled with great conversations, inspiring use cases, and valuable connections, the Biolevate team is back and ready for another full day of AI innovation. Whether you want to dive deeper into GenAI, explore concrete workflows, or simply discuss your challenges, we’d love to connect! ➡️ Follow the path in the video to find us : 𝗕𝗼𝗼𝘁𝗵 𝗛𝟲 - #𝘼𝙄 𝙛𝙤𝙧 𝙝𝙚𝙖𝙡𝙩𝙝
-
It’s on! Adopt AI - Grand Palais kicks off this morning! The Biolevate team is live on 𝗔𝗜 𝗳𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵 𝘇𝗼𝗻𝗲 and ready for two exciting days 📍Come meet us at 𝗕𝗼𝗼𝘁𝗵 𝗛𝟲
-
🚨 D-1 : Adopt AI - Grand Palais is almost there! Biolevate team is excited to kick off two days of innovation and meaningful conversations around the future of AI in healthcare ➡️ Booth H6 🎤 Tomorrow at 2:20 PM – Start-up Stage “𝗪𝗵𝘆 𝗰𝗵𝗮𝘁𝗯𝗼𝘁𝘀 𝗮𝗿𝗲 𝘁𝗵𝗲 𝘄𝗼𝗿𝘀𝘁 𝘄𝗮𝘆 𝘁𝗼 𝘂𝘀𝗲 𝗚𝗲𝗻𝗔𝗜?” with Antoine de Torcy Curious to learn more? Marie Barbier, Cécile-Aurore Wotawa, Cloé Nkamsao-Pluton, Marie Lorraine Gerard, Alexandre Olivier, Maxime Gobin, PhD, Pierre-Yves Doireau, joel Belafa, Jérôme Cabannes, Nathan Di C. and the team will be happy to connect!
-
-
Biolevate reposted this
🚨 D-4 days before 𝗔𝗜 𝗳𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵 as part of Adopt AI - Grand Palais! Don’t miss Antoine de Torcy, Biolevate’s Chief AI & Product Officer, on the Start-up Stage: 🎤 “Why chatbots are the worst way to use GenAI?” 🕑 2:20 PM – November 25 📍 Start-up Stage 👉 Add to your calendar : https://urls.fr/kwmVzN Join this session to uncover why relying on chatbots wastes GenAI’s potential and 𝗹𝗲𝗮𝗿𝗻 𝗵𝗼𝘄 𝗲𝗻𝗱-𝘁𝗼-𝗲𝗻𝗱, 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝘃𝗲 𝘄𝗼𝗿𝗸𝗳𝗹𝗼𝘄𝘀 𝗱𝗿𝗶𝘃𝗲 𝗿𝗲𝗮𝗹 𝗥𝗢𝗜 𝗮𝗻𝗱 𝗺𝗲𝗮𝘀𝘂𝗿𝗮𝗯𝗹𝗲 𝗶𝗺𝗽𝗮𝗰𝘁 𝗮𝗰𝗿𝗼𝘀𝘀 𝘆𝗼𝘂𝗿 𝗼𝗿𝗴𝗮𝗻𝗶𝘇𝗮𝘁𝗶𝗼𝗻. Stop by 𝗕𝗼𝗼𝘁𝗵 𝗛𝟲 to meet the Biolevate team and explore how our knowledge platform enables organizations to implement GenAI with trust, governance, and scalable AI workflows. #AIforHealth #AdoptAISummit #GrandPalais #AIActionSummit #GenAI #TrustworthyAI #HealthcareInnovation
-
-
🚨 D-4 days before 𝗔𝗜 𝗳𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵 as part of Adopt AI - Grand Palais! Don’t miss Antoine de Torcy, Biolevate’s Chief AI & Product Officer, on the Start-up Stage: 🎤 “Why chatbots are the worst way to use GenAI?” 🕑 2:20 PM – November 25 📍 Start-up Stage 👉 Add to your calendar : https://urls.fr/kwmVzN Join this session to uncover why relying on chatbots wastes GenAI’s potential and 𝗹𝗲𝗮𝗿𝗻 𝗵𝗼𝘄 𝗲𝗻𝗱-𝘁𝗼-𝗲𝗻𝗱, 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝘃𝗲 𝘄𝗼𝗿𝗸𝗳𝗹𝗼𝘄𝘀 𝗱𝗿𝗶𝘃𝗲 𝗿𝗲𝗮𝗹 𝗥𝗢𝗜 𝗮𝗻𝗱 𝗺𝗲𝗮𝘀𝘂𝗿𝗮𝗯𝗹𝗲 𝗶𝗺𝗽𝗮𝗰𝘁 𝗮𝗰𝗿𝗼𝘀𝘀 𝘆𝗼𝘂𝗿 𝗼𝗿𝗴𝗮𝗻𝗶𝘇𝗮𝘁𝗶𝗼𝗻. Stop by 𝗕𝗼𝗼𝘁𝗵 𝗛𝟲 to meet the Biolevate team and explore how our knowledge platform enables organizations to implement GenAI with trust, governance, and scalable AI workflows. #AIforHealth #AdoptAISummit #GrandPalais #AIActionSummit #GenAI #TrustworthyAI #HealthcareInnovation
-
-
🚀 Biolevate is thrilled to announce its participation in the 𝗔𝗜 𝗳𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵 𝗦𝘂𝗺𝗺𝗶𝘁, taking place as part of Adopt AI - Grand Palais – next week in Paris. This 8th edition will bring together global leaders, innovative technologies, and forward-thinking approaches to accelerate the transformation of healthcare through AI, and Biolevate is proud to be part of this journey. 📅 Save the date: 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟮𝟱–𝟮𝟲, 𝟮𝟬𝟮𝟱 📍 Meet us at 𝗕𝗼𝗼𝘁𝗵 𝗛𝟲 🎤 Don’t miss our pitch by Antoine de Torcy on Nov 25 - 2.20 pm We look forward to connecting with researchers, industry leaders, and innovators shaping the next era of AI in healthcare, as Biolevate enables organizations to implement GenAI through a knowledge platform that accelerates the entire value chain with trust, governance, and scalable AI workflows. 💥 Stop by Booth H6 - Biolevate team can’t wait to meet you and explore your use cases. #AIforHealth #AdoptAISummit #GrandPalais #AIActionSummit
-
-
Biolevate reposted this
We’ve kept quiet… but only because we’ve been building. 🚀 From powerful new AI features to key platform upgrades, Biolevate Platform is taking Healthcare AI to the next level. 👉 Swipe to catch up on what’s new in November.
-
Biolevate reposted this
Lead Omic Scientist @Biolevate⎮Artificial Intelligence⎮Research & Innovation⎮Pharmacology & Dermocosmetic & Chemistry
Today, at #Leukemia360, Biolevate team had a fascinating overview of French initiatives in Leukemia with demonstration on how industry, academia and associations accelerate innovation through collaboration. From T-cell activation advances in ALL (Matthieu Simonin & Guillaume P. Andrieu ) to in silico modeling approaches presented by Claire Biot , and the ongoing transformation of clinical trials described by Norbert VEY, each contribution underscored the strong collective momentum at play. This ecosystem is further reinforced by the key role of OPALE Carnot Institute (Hervé Dombret Pascal Deschaseaux) and the Carnot network, both driving numerous initiatives and spinoffs across Europe. The workshop sessions also highlighted the breadth of current efforts, from an integrative drug-testing platform capable of screening up to 1500 molecules with promising combinations already emerging, to the specific challenges of pediatric Leukemia research shaped by unique biology, limited patient numbers, and complex regulatory constraints that delay treatment access (Virginie gandemer, Marion Strullu, Arnaud Petit) I was also pleased to present for the first time Biolevate’s work on AML and how we combine AI with deep biological expertise to adapt therapies to the specific signatures of each patient. And finally it was a good opportunity to talk with a lot of experts from that field ! See you next years with more insigths ! #Leukemia #Innovation #AI #Leukemia360 #Biolevate #Oncology #AML
-